Endophenotypes in bipolar disorder

被引:190
|
作者
Lenox, RH
Gould, TD
Manji, HK
机构
[1] NIMH, Mol Pathophysiol Lab, Bethesda, MD 20892 USA
[2] Aventis Pharmaceut, CNS Res & Drug Discovery, Bridgewater, NJ USA
来源
AMERICAN JOURNAL OF MEDICAL GENETICS | 2002年 / 114卷 / 04期
关键词
biological marker; subclinical trait; vulnerability marker; circadian rhythms; genetics;
D O I
10.1002/ajmg.10360
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The search for genes in bipolar disorder has provided numerous genetic loci that have been linked to susceptibility to developing the disorder. However, because of the genetic heterogeneity inherent in bipolar disorder, additional strategies may need to be employed to fully dissect the genetic underpinnings. One such strategy involves reducing complex behaviors into their component parts (endophenotypes). Abnormal neurophysiological, biochemical, endocrinological, neuroanatomical, cognitive, and neuropsychological findings are characteristics that often accompany psychiatric illness. It is possible that some of these may eventually be useful in subdefining complex genetic disorders, allowing for improvements in diagnostic assessment, genetic linkage studies, and development of animal models. Findings in patients with bipolar disorder that may eventually be useful as endophenotypes include abnormal regulation of circadian rhythms (the sleep/wake cycle, hormonal rhythms, etc.), response to sleep deprivation, P300 event-related potentials, behavioral responses to psychostimulants and other medications, response to cholinergics, increase in white matter hyperintensities (WHIs), and biochemical observations in peripheral mononuclear cells. Targeting circadian rhythm abnormalities may be a particularly useful strategy because circadian cycles appear to be an inherent evolutionarily conserved function in all organisms and have been implicated in the pathophysiology of bipolar disorder. Furthermore, lithium has been shown to regulate circadian cycles in diverse species, including humans, possibly through inhibition of glycogen synthase kinase 3-beta (GSK-3beta), a known target of lithium. Published 2002 Wiley-Liss, Inc.(dagger)
引用
收藏
页码:391 / 406
页数:16
相关论文
共 50 条
  • [1] Emotional endophenotypes and bipolar disorder
    Dubois, M.
    Azorin, J-M
    Fakra, E.
    Adida, M.
    Belzeaux, R.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2012, 38 : S85 - S92
  • [2] Neurocognitive endophenotypes for bipolar disorder
    Frantom, Linda V.
    Allen, Daniel N.
    Cross, Chad L.
    BIPOLAR DISORDERS, 2008, 10 (03) : 387 - 399
  • [3] Evaluating endophenotypes for bipolar disorder
    Riccardo Guglielmo
    Kamilla Woznica Miskowiak
    Gregor Hasler
    International Journal of Bipolar Disorders, 9
  • [4] Neuropsychological endophenotypes for bipolar disorder
    Glahn, D. C.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S23 - S23
  • [5] Candidate endophenotypes in bipolar disorder
    Young, AH
    BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 17S - 17S
  • [6] Behavioral Endophenotypes in Bipolar Disorder
    Leibenluft, Ellen
    BIOLOGICAL PSYCHIATRY, 2009, 65 (08) : 94S - 94S
  • [7] Evaluating endophenotypes for bipolar disorder
    Guglielmo, Riccardo
    Miskowiak, Kamilla Woznica
    Hasler, Gregor
    INTERNATIONAL JOURNAL OF BIPOLAR DISORDERS, 2021, 9 (01)
  • [8] BIPOLAR DISORDER - FROM ENDOPHENOTYPES TO TREATMENT
    Hranov, Luchezar G.
    Marinova, Petra
    Stoyanova, Maria
    Pandova, Milena
    Hranov, Georgi
    PSYCHIATRIA DANUBINA, 2013, 25 (03) : 284 - 291
  • [9] Grey Matter Endophenotypes in Bipolar Disorder
    McIntosh, Andrew Mark
    BIOLOGICAL PSYCHIATRY, 2009, 65 (08) : 94S - 94S
  • [10] Psychosis endophenotypes in schizophrenia and bipolar disorder
    Thaker, Gunvant
    SCHIZOPHRENIA BULLETIN, 2008, 34 (04) : 720 - 721